查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1991362

全球電子臨床解決方案市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global E-Clinical Solutions Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 178 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

電子臨床解決方案市場預計將從 2025 年的 119.5 億美元成長到 2034 年的 417.5 億美元，預計從 2026 年到 2034 年將以 14.91% 的複合年成長率成長。

隨著製藥和生物技術公司採用數位化技術管理臨床試驗，全球電子臨床解決方案市場正顯著成長。電子臨床解決方案包括有助於組織臨床數據、監控試驗並提高研究效率的軟體平台。這些系統使研究人員能夠更有效地收集和分析患者數據，減少錯誤，並改善整體試驗管理。

市場的主要促進因素包括臨床試驗日益複雜化以及對高效數據管理的需求。製藥公司正依靠數位化解決方案來簡化研究方法並加速藥物研發。此外，雲端運算和先進分析技術的應用也提高了他們管理臨床試驗中產生的大規模資料集的能力。

隨著醫療產業數位轉型不斷推進，電子臨床解決方案市場依然保持強勁勢頭。人工智慧和數據整合技術的進步可望進一步提升臨床研究能力。隨著對更快、更有效率的藥物研發需求日益成長，電子臨床平台的應用預計將持續擴大。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球電子臨床解決方案市場：依產品分類

  • 市場分析、洞察與預測
  • 電子資料擷取（EDC）和臨床資料管理系統（CDMS）
  • 臨床試驗管理系統（CTMS）
  • 臨床分析平台
  • 隨機化與臨床實驗藥物供應管理（RTSM）
  • 臨床數據整合平台
  • 電子臨床結果評估（eCOA）
  • 安全解決方案
  • 電子考試主文件（eTMF）

第5章 全球電子臨床解決方案市場：以交付方式分類

  • 市場分析、洞察與預測
  • 基於雲端和網路的
  • 現場

第6章 全球電子臨床解決方案市場：依發展階段分類

  • 市場分析、洞察與預測
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第7章 全球電子臨床解決方案市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院/醫療保健機構
  • CRO
  • 學術機構
  • 製藥和生物技術公司
  • 醫療設備製造商

第8章 全球電子臨床解決方案市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • IQVIA Holdings Inc
    • Dassault Systemes SE
    • Parexel International Corporation
    • BioClinica Inc
    • EClinicalWorks Inc
    • Veeva Systems Inc
    • Medidata Solutions Inc
    • ICON Plc
    • IBM Watson Health（unit Of IBM Corporation）
    • Oracle Corporation
    • Castor EDC
    • EClinical Solutions LLC
    • CRF Health
    • ERT Clinical
    • Datatrak International Inc
簡介目錄
Product Code: VMR11213540

The E-Clinical Solutions Market size is expected to reach USD 41.75 Billion in 2034 from USD 11.95 Billion (2025) growing at a CAGR of 14.91% during 2026-2034.

The global e-clinical solutions market has grown significantly as pharmaceutical and biotechnology companies adopt digital technologies to manage clinical trials. E-clinical solutions include software platforms that help organize clinical data, monitor trials, and improve research efficiency. These systems enable researchers to collect and analyze patient data more effectively, reducing errors and improving overall trial management.

Key drivers of the market include increasing complexity of clinical trials and the need for efficient data management. Pharmaceutical companies rely on digital solutions to streamline research processes and accelerate drug development. Additionally, the use of cloud computing and advanced analytics has improved the ability to manage large datasets generated during clinical studies.

The future prospects for the e-clinical solutions market remain strong as digital transformation continues across the healthcare industry. Advances in artificial intelligence and data integration technologies may enhance clinical research capabilities. As demand for faster and more efficient drug development grows, the adoption of e-clinical platforms is expected to increase.

MARKET SEGMENTATION

By Product

  • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
  • Clinical Trial Management Systems (CTMS)
  • Clinical Analytics Platforms
  • Randomization and Trial Supply Management (RTSM)
  • Clinical Data Integration Platforms
  • Electronic Clinical Outcome Assessment (eCOA)
  • Safety Solutions
  • Electronic Trial Master File (eTMF)

By Delivery Mode

  • Cloud And Web-Based
  • On-Premise

By Development Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By End Use

  • Hospitals/Healthcare Providers
  • CROs
  • Academic Institutes
  • Pharma & Biotech Organizations
  • Medical Device Manufacturers

COMPANIES PROFILED

  • IQVIA Holdings Inc, Dassault Systmes SE, Parexel International Corporation, BioClinica Inc, eClinicalWorks Inc, Veeva Systems Inc, Medidata Solutions Inc, ICON plc, IBM Watson Health unit of IBM Corporation, Oracle Corporation, Castor EDC, eClinical Solutions LLC, CRF Health, ERT Clinical, Datatrak International Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL E-CLINICAL SOLUTIONS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Clinical Trial Management Systems (CTMS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Clinical Analytics Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Randomization and Trial Supply Management (RTSM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Clinical Data Integration Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Electronic Clinical Outcome Assessment (eCOA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Safety Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Electronic Trial Master File (eTMF) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Delivery Mode
  • 5.2. Cloud And Web-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. On-Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL E-CLINICAL SOLUTIONS MARKET: BY DEVELOPMENT PHASE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Development Phase
  • 6.2. Phase I Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Phase II Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Phase III Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Phase IV Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL E-CLINICAL SOLUTIONS MARKET: BY END USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End Use
  • 7.2. Hospitals/Healthcare Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Pharma & Biotech Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Medical Device Manufacturers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL E-CLINICAL SOLUTIONS MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Delivery Mode
    • 8.2.3 By Development Phase
    • 8.2.4 By End Use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Delivery Mode
    • 8.3.3 By Development Phase
    • 8.3.4 By End Use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Delivery Mode
    • 8.4.3 By Development Phase
    • 8.4.4 By End Use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Delivery Mode
    • 8.5.3 By Development Phase
    • 8.5.4 By End Use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Delivery Mode
    • 8.6.3 By Development Phase
    • 8.6.4 By End Use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL E-CLINICAL SOLUTIONS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 IQVIA Holdings Inc
    • 10.2.2 Dassault Systemes SE
    • 10.2.3 Parexel International Corporation
    • 10.2.4 BioClinica Inc
    • 10.2.5 EClinicalWorks Inc
    • 10.2.6 Veeva Systems Inc
    • 10.2.7 Medidata Solutions Inc
    • 10.2.8 ICON Plc
    • 10.2.9 IBM Watson Health (unit Of IBM Corporation)
    • 10.2.10 Oracle Corporation
    • 10.2.11 Castor EDC
    • 10.2.12 EClinical Solutions LLC
    • 10.2.13 CRF Health
    • 10.2.14 ERT Clinical
    • 10.2.15 Datatrak International Inc